Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis

Journal of Clinical Immunology

Volumn 27, Issue 4, 2007, Pages 378-387

  Gabeta, Stella ^a   Norman, Gary L ^b   Liaskos, Christos ^a,c   Papamichalis, Panagiotis A ^a   Zografos, Theodoros ^a   Garagounis, Athanasios ^a   Rigopoulou, Eirini I ^a,c   Dalekos, George N ^a,c  

^a UNIVERSITY OF THESSALY   (Greece)

^b INOVA DIAGNOSTICS INC   (United States)

^c INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

Author keywords

Antimitochondrial antibodies; Enzyme linked immunosorbent assay (ELISA); Immunoglobulins; Liver autoimmunity; Primary biliary cirrhosis (PBC)

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MITOCHONDRION ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MITOCHONDRIA, LIVER; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 34250166182     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-007-9092-0     Document Type: Article

References (42)

1. Neuberger J: Primary biliary cirrhosis. Lancet 350:875-879, 1997
2. Bogdanos DP, Baum H: Antimitochondrial and other autoantibodies. Clin Liver Dis 7:759-77, 2003
3. Jones DE: Autoantigens in primary biliary cirrhosis. J Clin Pathol 53:813-821, 2000
4. Rigopoulou EI, Davies ET, Pares A, Zachou K, Liaskos C, Bogdanos DP, Rodes J, Dalekos GN, Vergani D: Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 54:528-532, 2005
5. Wesierska-Gadek J, Penner E, Battezzati PM, Selmi C, Zuin M, Hitchman E, Worman HJ, Gershwin ME, Podda M, Invernizzi P: Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 43:1135-1144, 2006
6. Rigopoulou EI, Dalekos GN: Anti-sp100 antibodies in primary biliary cirrhosis. Scand J Gastroenterol 39:406-407, 2004
7. Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J: Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25:298-310, 2005
8. Zachou K, Liaskos C, Rigopoulou EI, Gabeta S, Papamichalis P, Gatselis N, Georgiadou S, Dalekos GN: Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver disease. Clin Immunol 119:203-212, 2006
9. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OFW: Natural history of early primary biliary cirrhosis. Lancet 348:1399-1402, 1996
10. Neuberger J, Bradwell A: Anti-mitochondrial antibodies in primary biliary cirrhosis. J Hepatol 37:712-716, 2002
11. Nishio A, Keefe EB, Gershwin ME: Immunopathogenesis of primary biliary cirrhosis. Semin Liver Dis 22:291-302, 2002
12. Moteki S, Leung PSC, Dickson ER, VanTHiel DH, Galperin C, Buch T, Alarcon-Segovia D, Kershenobich D, Kawano K, Coppel RL, Matuda S, Gershwin ME: Epitope mapping and reactivity of autoantibodies to the E-2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Hepatology 23:436-44, 1996
13. Zachou K, Rigopoulou EI, Tsikrikoni A, Alexandrakis MG, Passam F, Kyriakou DS, Stathakis NE, Dalekos GN: Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production. J Autoimmun 25:283-288, 2005
14. Kyriakou DS, Alexandrakis MG, Zachou K, Passam F, Stathakis NE, Dalekos GN: Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1. J Hepatol 39:679-685, 2003
15. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A: Prognosis in primary biliary cirrhosis; model for decision making. Hepatology 10:1-7, 1989
16. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RAF, Dickson ER: Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl 6:489-494, 2000
17. Ludwig J, Dickson ER, McDonald GS: Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379:103-112, 1978
18. Beuers U: Hepatic overlap syndromes. J Hepatol 42:S93-S99, 2005
19. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston ALWF, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RNM, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Büschenfelde K-H, Mieli-Vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann BC, Reed DW, Rodes J, Schalm SW, Scheuer PJ, Schrumpf E, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: International autoimmune hepatitis group: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929-938, 1999
20. Vergani D, Alvarez F, Bianchi FB, Cancado ELR, Mackay IR, Manns MP, Nishioka M, Penner E: Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group. J Hepatol 41:677-683, 2004
21. Dalekos GN, Makri E, Loges S, Obermayer-Straub P, Zachou K, Tsikrikas T, Schmidt E, Papadamou G, Manns MP: Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece. Eur J Gastroenterol Hepatol 14:35-42, 2002
22. Dalekos GN, Wedemayer H, Obermayer-Straub P, Kayser A, Barut A, Frank H, Manns MP: Epitope mapping of cytochrome P450 2D6 autoantigen in patients with chronic hepatitis C during α-interferon treatment. J Hepatol 30:366-375, 1999
23. Guéguen P, Dalekos G, Nousbaum J-B, Zachou K, Putterman C, Youinou P, Renaudineau Y: Double reactivity against actin and α-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol 26:495-505, 2006
24. Nezu S, Tanaka A, Yasui H, Imamura M, Nakajima H, Ishida H, Takahashi S: Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol 21:1448-1454, 2006
25. Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, Hayashida K, Isomoto H, Mizuta Y, Murase K, Murata I, Kohno S: Evaluation of newly developed ELISA using MESACUP-2 test mitochondrial M2 kit for the diagnosis of primary biliary cirrhosis. Clin Biochem 36:203-210, 2003
26. Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, Fujikawa H, Gerschwin ME: Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 34:243-248, 2001
27. Muratori P, Muratori L, Gershwin ME, Czaja AJ, Pappas G, Maccariello S, Granito A, Cassani F, Loria P, Lenzi M, Bianchi FB: 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol 135:154-158, 2004
28. Tanaka A, Miyakawa H, Luketic VAC, Kaplan M, Storch WB, Gershwin ME: The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary biliary cirrhosis. Cell Mol 48:295-299, 2002
29. Invernizzi P, Podda M, Battezatti PM, Crogignani A, Zuin M, Hitchman E, Maggioni M, Meroni PL, Penner E, Wesierska-Gadek J: Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 34:366-372, 2001
30. Itoh S, Ichida T, Yoshida T, Hayakawa A, Uchida M, Tashiro-Itoh T, Matsuda Y, Ishihara K, Asakura H: Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 13:257-265, 1998
31. Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, Ueki T, Daikoku M, Yano K, Matsumoto T, Migita K, Yatsuhashi H, Ito M, Masaki N, Adachi H, Watanabe Y, Nakamura Y, Saoshiro T, Sodeyama T, Koga M, Shimoda S, Ishibashi H: Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol 42:386-392, 2005
32. Van Norstrand MD, Malinchoc M, Lindor KD, Therneau TM, Gershwin ME, Leung PS, Dickson ER, Homburger HA: Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology 25:6-11, 1997
33. Joshi S, Cauch-Dudek K, Heathcote J, Lindor K, Jorgensen R, Klein R: Antimitochondrial antibody profiles: Are they valid prognostic indicators in primary biliary cirrhosis? Amer J Gastroenterol 97:999-1002, 2002
34. Kisand KE, Kisand KV, Karvonen A-L, Vuoristo M, Mattila J, Makinen J, Uibo R: Antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: Correlation with histology. APNIS 106:884-892, 1998
35. Nakajama M, Shimizu H, Miyazaki A, Watanabe S, Kitami N, Sato N: Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: Is autoimmune cholangitis an early stage of primary bilary cirrhosis? J Gastroenterol 34:607-612, 1999
36. Masuda J, Omagari K, Ohba K, Hazama H, Kadokawa Y, Kinoshita H, Hayashida K, Ishibashi H, Nakanuma Y, Kohno S: Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis. Dig Dis Sci 48:932-938, 2003
37. Omagari K, Kadokawa Y, Nakamura M, Akazawa S, Ohba K, Ohnita K, Mizuta Y, Daikoku M, Yatsuhashi H, Ishibashi H, Kohno S: IgA class antibodies to 2-oxo-acid dehydrogenase complex are not predictive markers of histopathological progression in primary biliary cirrhosis. Autoimmunity 39:107-112, 2006
38. Nishio A, Van de Water J, Leung PS, Joplin R, Neuberger JM, Lake J, Bjorkland A, Totterman TH, Peters M, Worman HJ, Ansari AA, Coppel RL, Gershwin ME: Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology 25:1085-1089, 1997
39. Floreani A, Baragiotta A, Pizzuti D, Martines D, Cecchetto A, Chiarelli S: Mucosal IgA defect in primary biliary cirrhosis. Amer J Gastroenterol 97:508-510, 2002
40. Gatselis NK, Stefos A, Gioti C, Rigopoulou EI, Dalekos GN: Primary biliary cirrhosis and Henoch-Schonlein purpura: Report of two cases and review of the literature. Liver Intl 27:280-283, 2007
41. Malmborg AC, Shultz DB, Luton F, Mostov KE, Richly E, Leung PS, Benson GD, Ansari AA, Coppel RL, Gershwin ME, Van de Water J: Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis. J Autoimmun 11:573-580, 1998
42. Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, Coppel RL: Primary biliary cirrhosis: An orchestrated immune response against epithelial cells. Immunol Rev 174:210-25, 2000